
All Family Pharmacy is owned by All Family Pharmacy LLC, a privately held Boca Raton, Florida company owned by managing member Thomas W. Kuenzler. Operating at allfamilypharmacy.com since 2018, the mail-order pharmacy dispenses more than 200 medications nationwide through an online ordering model paired with telehealth-affiliated prescribers, and it is known for providing access to ivermectin and hydroxychloroquine.
| Brand | Parent Company | Ownership Type |
|---|---|---|
| All Family Pharmacy | All Family Pharmacy LLC | Product line |
All Family Pharmacy LLC was formed on October 17, 2017, in Florida, and its pharmacy National Provider Identifier was enumerated on February 28, 2018. It was established in Boca Raton as a community and retail pharmacy holding a Florida license, a conventional independent pharmacy in its first years.
The business transformed during the COVID-19 pandemic. As demand surged for ivermectin and hydroxychloroquine and many mainstream pharmacies and physicians refused to dispense them for COVID use, All Family Pharmacy adopted a direct-to-consumer mail-order model. Customers selected medications online, completed a medical intake form, and received prescriptions by mail after affiliated prescriber review. The model converted a local pharmacy into a national one.
Growth was driven by media. From around 2023 the company sponsored conservative podcasts and broadcasts, with advertising reads by figures including Donald Trump Jr., Dan Bongino, Laura Ingraham, Matt Gaetz, and Candace Owens, according to reporting by Media Matters and The Atlantic. The marketing made All Family Pharmacy one of the most recognizable direct-to-consumer medication sources in right-leaning media without ever needing conventional pharmaceutical marketing.
The product positioning widened beyond the headline drugs. The company now advertises access to more than 200 medications, positioning itself as a general cash-pay mail-order alternative to insurance-tied pharmacies while keeping ivermectin and hydroxychloroquine availability as its signature draw.
The political environment through 2025 and 2026 moved in the brand's favor. Multiple states passed laws permitting over-the-counter ivermectin sales, and the medical freedom policy agenda gave its core market mainstream political legitimacy. The pharmacy continued operating from its Boca Raton base, with routine administrative updates to its Florida filings in 2025 and 2026.
Is All Family Pharmacy a legitimate pharmacy?
All Family Pharmacy LLC is a licensed Florida community/retail pharmacy with an active NPI record. It is a real dispensing pharmacy, though it has drawn controversy over its marketing of ivermectin and hydroxychloroquine and carries an F rating from the Better Business Bureau.
Who owns All Family Pharmacy?
The pharmacy is owned by Thomas W. Kuenzler, who is listed as managing member and owner in its Florida LLC filings and NPI record. It has no parent company or outside investors.
When was All Family Pharmacy founded?
The LLC was formed on October 17, 2017, and its pharmacy NPI was enumerated in February 2018.
Is All Family Pharmacy publicly traded?
No. All Family Pharmacy LLC is a private Florida limited liability company with no stock listing.
Can All Family Pharmacy sell ivermectin without a prescription?
The company operates a telehealth-adjacent model where affiliated prescribers review intake forms and write prescriptions. Several states passed laws in 2025 allowing over-the-counter ivermectin sales, though the FDA has not approved ivermectin for COVID-19 treatment or prevention and over-the-counter status varies by state.
All Family Pharmacy has attracted significant public controversy. Media Matters documented in 2024 that the pharmacy sponsored conservative media figures while providing easy access to ivermectin and hydroxychloroquine, drugs without evidence for COVID-19 use. The Atlantic reported in 2025 that the company promoted ivermectin to audiences of right-wing shows, describing it as central to the drug's role as a political symbol.
Investigative reporting by the consumer watchdog Consumer Diligence alleged in 2025 that test orders were shipped to states where the pharmacy did not appear on out-of-state pharmacy registries and that orders were approved despite disclosed contraindications. These claims come from an advocacy organization rather than a regulator and remain unrebutted publicly.
The Better Business Bureau rates the pharmacy F, citing unanswered complaints, and it is not accredited. As of November 2026 no FDA or state pharmacy board enforcement action has been publicly announced, and the pharmacy maintains its Florida license and active NPI status.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Cvs Health | USA | 2014 | Mass market | United states | All Genders | |
| Chempro | Australia | 1996 | Mass market | Australia | All Genders |
Healthcare PharmaceuticalsOwned by CVS Health Corporation
Specialty pharmacy service of CVS Health, providing mail-order and clinical support for complex, high-cost medications treating chronic and rare conditions.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Market Positioning: All Family Pharmacy competes with 2 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by All Family Pharmacy LLC, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by AstraZeneca PLC
British-Swedish pharmaceutical brand behind Tagrisso and Farxiga, owned by publicly traded AstraZeneca PLC formed by merger in 1999.
AstraZeneca operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Boehringer Ingelheim
German family-owned pharmaceutical brand behind Jardiance and Spiriva, founded in 1885 and still controlled by the Boehringer family.
Boehringer Ingelheim operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Eli Lilly and Company
American pharmaceutical brand behind Mounjaro and Zepbound, owned by publicly traded Eli Lilly and Company founded in Indianapolis in 1876.
Eli Lilly operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by GoodRx Holdings, Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
GoodRx operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Sanofi
French pharmaceutical brand behind Lantus and Dupixent, owned by publicly traded Sanofi SA founded in Paris in 1973.
Sanofi operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Zocdoc, Inc.
Online healthcare marketplace where patients find in-network doctors and book appointments instantly, a private New York company valued at $1.8 billion.
Zocdoc operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.